产品展示
PRODUCT DISPLAY
最新促销您现在的位置: 秒速牛牛 > 最新促销

MatriksBiotek品牌产品列表介绍

供应数量:21

发布日期:2019/4/23

有效日期:2020/4/23

原 产 地:

已获点击:21

打印当前页

免费咨询:0512-67156496

发邮件给我们:info@ebiomall.com

分享到:

MatriksBiotek品牌产品列表介绍


MatrikSBIotek®Co。,作为一家成立于2002年的生物技术公司,正在庆祝其15年的业务。 以生产为导向的公司致力于研究和创新免疫,分子和工具,将有助于健康。 在市场上使用生物药物测试SHIKARI®ELISA试剂盒,自从在全球市场上首次生产和商业化以来已有10年的历史。 

在36个国家和30多家制药公司充满信心地使用和/或使用我们的产品。 生物制剂(主要是人源化重组单克隆抗体)在某些疾病中作为药物的使用引起每个单独治疗的人的有效性问题。 监测药物水平和抗体在管理对重组和/或人源化抗体的反应缺乏或丧失方面发挥着新的作用(即,确认治疗持续,剂量调整,提供转换为另一种药剂或不同药剂的理由 一类生物制剂)。

 

MatriksBiotek品牌产品列表介绍

 

MatrikSBIotek介绍

Reference CodeProduct NameDescription
TR-Q-INFLIXIv2Q-INFLIXIEnzyme immunoassay for the quantitative determination of free Infliximab (Remicade®) in serum and plasma
TR-ATIv5Q-ATIEnzyme immunoassay for the qualitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
TR-ATIv6Q-ATIEnzyme immunoassay for the quantitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
TR-ATIv8Q-ATI DUOEnzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to infliximab (Remicade®) in serum and plasma。
TR-ADAv1Q-ADAEnzyme immunoassay for the quantitative determination of free adalimumab (Humira®) in serum and plasma
TR-AADAv1S-ATAEnzyme immunoassay for the qualitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
TR-AADAv2S-ATAEnzyme immunoassay for the quantitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
TR-AADAv4S-ATA DUOEnzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to adalimumab (Humira®) in serum and plasma
TR-ETAv2Q-ETAEnzyme immunoassay for the quantitative determination of free Etanercept (Enbrel) in serum and plasma
TR-AETAv2S-ATEEnzyme immunoassay for the qualitative determination of antibodies to etanercept in serum and plasma
TR-BEVAv2Q-BEVAEnzyme immunoassay for the quantitative determination of Bevacizumab (Avastin®) in serum and plasma
TR-ABEVAv1S-ATBEnzyme immunoassay for the qualitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
TR-ABEVAv2S-ATBEnzyme immunoassay for the quantitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
TR-RTXv2Q-RITUXEnzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-ARTXv1S-ATREnzyme immunoassay for the qualitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-ARTXv2S-ATREnzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TR-TRASv2Q-TRASEnzyme immunoassay for the quantitative determination of Trastuzumab (Herceptin®, Herclon®)
TR-ATRASv1S-ATTEnzyme immunoassay for the qualitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TR-ATRASv2S-ATTEnzyme immunoassay for the quantitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TR-GOLv1Q-GOLEnzyme immunoassay for the quantitative determination of free Golimumab (Simponi®) in serum and plasma。
TR-ATGv1S-ATGEnzyme immunoassay for the qualitative determination of antibodies to Golimumab in serum and plasma。
TR-CETv1Q-CETEnzyme immunoassay for the quantitative determination of free Cetuximab (Erbitux®) in serum and plasma.
TR-ATCv1S-ATCEnzyme immunoassay for the qualitative determination of antibodies to cetuximab in serum and plasma.
TR-ATCv2S-ATCEnzyme immunoassay for the quantitative determination of antibodies to cetuximab in serum and plasma。
TR-REMSv1Q-REMSEnzyme immunoassay for the quantitative determination of free Infliximab (Remsima®) in serum and plasma。
TR-AREMSv1S-AIREnzyme immunoassay for the qualitative determination of antibodies to Infliximab Remsima in serum and plasma。
TR-AREMSv2S-AIREnzyme immunoassay for the quantitative determination of antibodies to Infliximab Remsima in serum and plasma。
TR-AREMSv3S-AIREnzyme immunoassay for the semi-quantitative determination (screening) of total antibodies to Infliximab biosimilar (Remsima®) in serum and plasma.
TR-QDENv1Q-DENEnzyme immunoassay for the quantitative determination of Denosumab (Prolia®)in serum and plasma.
TR-AATDv1S-ATDEnzyme immunoassay for the qualitative determination of antibodies to Denosumab in serum and plasma.
TR-OMAv1Q-OMAEnzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) Remsima in serum and plasma。
TR-AATOv1S-ATOEnzyme immunoassay for the qualitative determination of antibodies to Omalizumab in serum and plasma。
TR-Q-NIVOv1Q-NIVOEnzyme immunoassay for the quantitative determination of Nivolumab (Opdivo®) in serum and plasma.
TR-ATNv1S-ATNEnzyme immunoassay for the qualitative determination of antibodies to Nivolumab in serum and plasma.
TR-PEMv1Q-PEMEnzyme immunoassay for the quantitative determination of Pembrolizumab (Keytruda®) in serum and plasma.
TR-A-PEMv1S-ATPEnzyme immunoassay for the qualitative determination of antibodies to Pembrolizumab in serum and plasma.
TR-AFAv1Q-AFAEnzyme immunoassay for the quantitative determination of specific anibodies to Filgrastim in serum and plasma.
TR-IPIv1Q-IPIEnzyme immunoassay for the quantitative determination of specific Ipilimumab(Yervoy®) in human serum and plasma.
TR-AIPIv1S-ATIEnzyme immunoassay for the qualitative determination of specific anibodies to Ipilimumab in serum and plasma。
TR-Q-AVEv1Q-AVEEnzyme immunoassay for the quantitative determination of specific Avelumab(Bavencio®) in human serum and plasma.
TR-A-AVEv1S-ATAVEnzyme immunoassay for the qualitative determination of specific anibodies to Avelumab in serum and plasma。
TR-RANv1Q-RANEnzyme immunoassay for the quantitative determination of free Ranibizumab in aqueous humour.
TR-RAMv1Q-RAMEnzyme immunoassay for the quantitative determination of free Ramucirumab in serum and plasma.
TR-ARAMv1S-ATRAMEnzyme immunoassay for the qualitative determination of antibodies to Ramucirumab in serum and plasma.
TR-CERTv2Q-CERTEnzyme immunoassay for the quantitative determination of Certolizumab in human serum and plasma
TR-Q-VEDOv1Q-VEDOEnzyme immunoassay for the quantitative determination of Vedolizumab in human serum and plasma
TR-ATVv1S-ATVEnzyme immunoassay for the qualitative determination of antibodies to Vedolizumab in human serum and plasma
TR-Q-USTv1Q-USTEnzyme immunoassay for the quantitative determination of Ustekinumab in human serum and plasma
TR-AUSTv1S-ATUEnzyme immunoassay for the qualitative determination of antibodies to Ustekinumab in human serum and plasma
 
在线客服